IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ROMANI, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.850
EU - Europa 2.435
AS - Asia 2.283
SA - Sud America 356
Continente sconosciuto - Info sul continente non disponibili 165
AF - Africa 55
OC - Oceania 9
AN - Antartide 1
Totale 11.154
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.653
SG - Singapore 773
CN - Cina 695
PL - Polonia 617
IT - Italia 554
BR - Brasile 290
DE - Germania 275
UA - Ucraina 250
HK - Hong Kong 241
VN - Vietnam 168
FI - Finlandia 159
GB - Regno Unito 146
FR - Francia 106
CA - Canada 98
TR - Turchia 83
BD - Bangladesh 82
IN - India 66
RU - Federazione Russa 66
IE - Irlanda 65
NL - Olanda 47
ID - Indonesia 34
MX - Messico 32
AR - Argentina 30
SE - Svezia 29
EE - Estonia 25
ZA - Sudafrica 24
IQ - Iraq 23
ES - Italia 21
JP - Giappone 20
HN - Honduras 12
LT - Lituania 12
AT - Austria 11
CZ - Repubblica Ceca 11
PK - Pakistan 11
BE - Belgio 10
EC - Ecuador 10
CR - Costa Rica 9
AU - Australia 8
KG - Kirghizistan 8
NI - Nicaragua 8
TT - Trinidad e Tobago 8
GP - Guadalupe 7
IL - Israele 7
KR - Corea 7
TW - Taiwan 7
BG - Bulgaria 6
CL - Cile 6
CO - Colombia 6
MY - Malesia 6
NP - Nepal 6
AE - Emirati Arabi Uniti 5
LK - Sri Lanka 5
MA - Marocco 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
CW - ???statistics.table.value.countryCode.CW??? 4
EG - Egitto 4
GT - Guatemala 4
JO - Giordania 4
KZ - Kazakistan 4
NG - Nigeria 4
PH - Filippine 4
PY - Paraguay 4
SV - El Salvador 4
UZ - Uzbekistan 4
VE - Venezuela 4
AL - Albania 3
DZ - Algeria 3
EU - Europa 3
JM - Giamaica 3
KE - Kenya 3
PT - Portogallo 3
SC - Seychelles 3
BB - Barbados 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
HU - Ungheria 2
LC - Santa Lucia 2
LU - Lussemburgo 2
LV - Lettonia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CU - Cuba 1
Totale 10.981
Salva come PNG Salva come JPEG
Città #
Warsaw 612
Ashburn 577
Fairfield 466
Singapore 458
San Jose 375
Woodbridge 328
Houston 284
Chandler 241
Seattle 223
Council Bluffs 220
Hong Kong 219
New York 193
Jacksonville 175
Wilmington 166
Beijing 150
The Dalles 144
Cambridge 143
Los Angeles 137
Ann Arbor 128
Dearborn 106
Helsinki 104
Brescia 103
Princeton 102
Dublin 64
Nanjing 63
Dallas 60
Istanbul 59
Munich 59
Milan 57
Lauterbourg 55
Columbus 48
Shanghai 46
Chicago 44
Dong Ket 44
Santa Clara 42
Buffalo 41
São Paulo 41
Ho Chi Minh City 39
San Francisco 34
London 33
Hanoi 32
Des Moines 31
Moscow 29
Toronto 29
North Bergen 28
Montreal 26
Orem 25
Phoenix 25
Denver 24
Jakarta 24
San Diego 23
Tallinn 23
Rome 22
Brooklyn 20
Redondo Beach 20
Shenyang 20
Tianjin 20
Jinan 19
Johannesburg 19
Turku 19
Chennai 18
Nanchang 18
Tokyo 17
Kunming 15
Central 14
Changsha 14
Hangzhou 14
Nuremberg 14
Hebei 13
Mexico City 13
Miami 13
Poplar 13
Atlanta 12
Charlotte 12
Guangzhou 12
Jiaxing 12
Stockholm 12
Boston 11
Paris 11
Zhengzhou 11
Manchester 10
Monmouth Junction 10
Verona 10
Kyiv 9
Amsterdam 8
Ankara 8
Belo Horizonte 8
Bishkek 8
Boardman 8
Lappeenranta 8
Managua 8
Memphis 8
Mumbai 8
Norwalk 8
Vancouver 8
Brussels 7
Falkenstein 7
Frankfurt am Main 7
Haiphong 7
Leawood 7
Totale 7.392
Salva come PNG Salva come JPEG
Nome #
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 376
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 374
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 347
Claudin3 is localized outside the tight junctions in human carcinomas 309
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 304
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 230
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 227
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 224
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 220
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 219
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 212
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 212
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 211
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 208
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 205
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 202
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 200
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 200
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 195
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 190
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 189
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 189
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. 187
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 187
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 187
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 180
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 178
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 175
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 171
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 162
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 160
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 156
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 156
Prenatal presentation and postnatal evolution of a patient with Jansen metaphyseal dysplasia with a novel missense mutation in PTH1R. 156
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 156
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 155
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 152
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 152
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 151
Stability of circulating miRNA in saliva: The influence of sample associated pre-analytical variables 146
OVEREXPRESSION OF EPIDERMAL GROWTH FACTOR TYPE-1 RECEPTOR (EGF-R1) IN CERVICAL CANCER: IMPLICATIONS FOR CETUXIMAB-MEDIATED THERAPY IN RECURRENT/METASTATIC DISEASE. 145
Uso di miRNA come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose 144
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 132
Integrated mutational landscape analysis of uterine leiomyosarcomas 130
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 128
The VEGF/VEGFR2 system in ovarian cancer: From functional to pharmacological significance 127
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 127
Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response. 127
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 122
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 122
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 121
HE4 and epithelial ovarian cancer : Comparison and clinical evaluation of two immunoassays and a combination algorithm 115
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 115
Human papillomavirus type 16 (HPV-16) virus-like particleL1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. 113
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 109
Revisiting the concept of neoadjuvant and induction therapy in head and neck cancer with the advent of immunotherapy 106
Trop-2 Overexpression in Poorly Differentiated Endometrial Endometrioid Carcinoma: Implications for Immunotherapy With hRS7, a Humanized Anti-Trop-2 Monoclonal Antibody 103
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer 103
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 100
The prognostic role of salivary miRNAs in oral squamous cell carcinoma: technical challenges and clinical perspectives 99
Finding the junction between claudins and endometrial carcinoma 91
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders 89
Identification of optimal reference RNAs to normalize miRNA expression data by qRT-PCR in formalin-fixed, paraffin-embedded lymph node tissue 83
Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies 79
Mammaglobin B (SCGB2A1) is a novel tumor antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy 61
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients 55
HPV16VLP L1-Specific CD8+ cytotoxic T lymphocytes (CTL) are equally effective as E7-specific CD8+ CTL in killing autologous HPV16 positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines 52
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodeling 46
Totale 11.154
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.784
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022374 0 0 0 0 5 32 48 28 26 97 38 100
2022/2023611 90 38 32 40 60 126 8 66 84 6 35 26
2023/2024775 38 25 78 56 43 189 45 45 124 44 15 73
2024/20251.425 28 41 29 246 112 148 109 51 137 94 265 165
2025/20263.336 310 273 213 472 391 263 562 134 207 285 173 53
2026/20271.032 162 129 221 433 87 0 0 0 0 0 0 0
Totale 11.154